08-18 Precipio, Inc., Q2 2026 Earnings Call, Aug 17, 2026
08-15 Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-15 Precipio Announces Q2-2026 Financial Results AQ
08-01 Precipio Announces Q2-2026 Shareholder Update Call AQ
06-29 Precipio, Inc.(NasdaqCM:PRPO) added to Russell 3000E Index CI
06-29 Precipio, Inc.(NasdaqCM:PRPO) added to Russell Microcap Index CI
06-29 Precipio, Inc.(NasdaqCM:PRPO) added to Russell 3000E Growth Benchmark CI
06-29 Precipio, Inc.(NasdaqCM:PRPO) added to Russell Microcap Growth Benchmark Index CI
06-12 Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting AQ
06-12 Precipio to Present at the Planet MicroCap Las Vegas AQ
05-19 Precipio, Inc., Q1 2026 Earnings Call, May 18, 2026
05-15 Precipio Announces Q1 2026 Financial Results AQ
05-15 Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-14 Management team’s 2025 market-based Options have vested AQ
05-07 Precipio Announces Q1-2026 Shareholder Update Call AQ
04-03 Precipio, Inc., Q4 2025 Earnings Call, Apr 02, 2026
03-31 Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-30 Precipio, Inc. Auditor Raises 'Going Concern' Doubt CI
03-13 Precipio Announces Q4 and year-end 2025 Shareholder Update Call AQ
03-11 Precipio Inc Announces Bloodhound BCR::ABL1 Assay For Chronic Myeloid Leukemia CI
03-10 Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay AQ
02-25 Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year AQ
01-15 Precipio Takes Major Steps Toward a Clean Balance Sheet AQ
12-05 Precipio, Inc. to Showcase Its BCR::ABL1 Panel At 2025 Ash (American Society of Hematology) Meeting CI
12-05 Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting AQ
No results match your criteria